Cargando…
Risks and Benefits of Magnesium Sulfate Tocolysis in Preterm Labor (PTL)
The U.S. Food and Drug Administration issued a drug safety communication on 05/30/2013 recommending “against prolonged use of magnesium sulfate to stop preterm labor (PTL) due to bone changes in exposed babies.” In September of 2013, The American Congress of Obstetrics and Gynecologists issued Commi...
Autores principales: | Elliott, John P., Morrison, John C., Bofill, James A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AIMS Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5690360/ https://www.ncbi.nlm.nih.gov/pubmed/29546168 http://dx.doi.org/10.3934/publichealth.2016.2.348 |
Ejemplares similares
-
The Evidence Regarding Maintenance Tocolysis
por: Elliott, John P., et al.
Publicado: (2013) -
Association between the prolonged use of magnesium sulfate for tocolysis and fracture risk among infants
por: Wen, Yung-Hsiang, et al.
Publicado: (2021) -
Subcutaneous Terbutaline Pump for Maintenance of Tocolysis following Arrest of Acute Preterm Labor
por: Singh, Kavita, et al.
Publicado: (2014) -
Long-Term Tocolysis With Magnesium Sulfate as a Risk Factor for Low Bone Mass: A Case Series
por: Iio, Kazuaki, et al.
Publicado: (2022) -
Prevention of Preterm Labour: 2011 Update on Tocolysis
por: Hubinont, C., et al.
Publicado: (2011)